|
Market Closed -
London S.E.
01:35:27 22/09/26 am AEST
|
5-day change | 1st Jan Change | ||
| 12,560.00 GBX | +0.48% |
|
+3.34% | -8.92% |
| 02:06am | European Equities Traded in the US as American depositary Receipts Rise in Monday Trading | MT |
| 11:53pm | Pharma sector doubles down on AI to slash costs, timelines | RE |
| Market Cap | 259B 226B 213B 194B 364B 24,842B 364B 2,550B 983B 12,655B 974B 952B 40,836B | P/E 2026 * |
21.3x | P/E 2027 * | 18.6x |
|---|---|---|---|---|---|
| Enterprise Value | 279B 243B 229B 209B 391B 26,729B 392B 2,744B 1,058B 13,616B 1,048B 1,025B 43,937B | EV / Sales 2026 * |
4.42x | EV / Sales 2027 * | 4.05x |
| Free-Float |
96.63% | Yield 2026 * |
2% | Yield 2027 * | 2.12% |
| Markets | Quality | ||
|---|---|---|---|
London S.E.
| AZN | Delayed | |
NYSE
| AZN | End-of-day quote | |
|
Nasdaq Stockholm
| AZN | Delayed | |
|
CBOE
| AZN | Real-time | |
|
CBOE
| AZNs | Real-time | |
|
CBOE
| AZN | Real-time | |
|
Tradegate
| ZEG | Real-time | |
|
Börse Stuttgart
| ZEG | Delayed | |
|
Mexican S.E.
| AZN1 N | End-of-day quote | |
|
Deutsche Boerse AG
| ZEG | Delayed | |
|
CBOE
| AZN | Real-time | |
|
Boerse Muenchen
| ZEG | Real-time | |
|
Berne S.E.
| 000982352 | End-of-day quote |
Last Transcript: AstraZeneca PLC
| 1 day | +0.13% | ||
| 1 week | +3.34% | ||
| Current month | +4.93% | ||
| 1 month | +2.61% | ||
| 3 months | -5.49% | ||
| 6 months | -8.60% | ||
| Current year | -8.92% |
| 1 week | 11,922 |  | 12,630.68 |
| 1 month | 11,552 | | 12,630.68 |
| Current year | 10,524 | | 15,732 |
| 1 year | 10,524 | | 15,732 |
| 3 years | 9,461 | | 15,732 |
| 5 years | 8,090.32 | | 15,732 |
| 10 years | 3,996 | | 15,732 |
| Manager | Title | Age | Since |
|---|---|---|---|
Pascal Soriot
CEO | Chief Executive Officer | 66 | 01/10/2012 |
Aradhana Sarin
DFI | Director of Finance/CFO | 52 | 01/08/2021 |
Jeffrey Pott
CMP | Compliance Officer | - | 01/01/2023 |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 70 | 06/04/1999 | |
Pascal Soriot
BRD | Director/Board Member | 66 | 01/10/2012 |
Philip Broadley
BRD | Director/Board Member | 65 | 27/04/2017 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 14/9/26 | Free | Chief Financial Officer | 73 | 0.0000% | ||
| 14/9/26 | Buy | Chairman | 2,500 | 0.0002% | ||
| 8/9/26 | Free | See Remarks | 1 | 0.0000% | - |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.48% | +3.34% | +9.22% | +15.38% | 259B | |
| +0.95% | +2.36% | +54.34% | +111.80% | 1,028B | |
| -0.13% | +1.27% | +54.82% | +66.84% | 651B | |
| +0.34% | +1.21% | +19.03% | +72.68% | 466B | |
| +2.24% | +0.94% | +34.56% | +45.31% | 346B | |
| +0.90% | +1.95% | +18.15% | +25.27% | 266B | |
| +1.95% | +3.18% | +37.63% | +46.10% | 208B | |
| -7.65% | -7.28% | -32.15% | -59.52% | 191B | |
| +0.33% | +3.17% | +34.28% | +100.68% | 186B | |
| +0.38% | +0.20% | +15.54% | -15.45% | 158B | |
| Average | +0.00% | +2.91% | +24.54% | +40.91% | 375.94B | |
| Weighted average by Cap. | +0.38% | +2.95% | +34.61% | +62.04% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 63.17B 55.07B 51.87B 47.24B 88.57B 6,051B 88.68B 621B 239B 3,083B 237B 232B 9,947B | 67.01B 58.43B 55.03B 50.11B 93.96B 6,420B 94.08B 659B 254B 3,270B 252B 246B 10,553B |
| Net income | 12.04B 10.5B 9.89B 9.01B 16.89B 1,154B 16.91B 118B 45.65B 588B 45.24B 44.24B 1,897B | 13.77B 12.01B 11.31B 10.3B 19.31B 1,319B 19.34B 135B 52.21B 672B 51.74B 50.59B 2,169B |
| Net Debt | 19.69B 17.17B 16.17B 14.73B 27.61B 1,887B 27.65B 194B 74.65B 961B 73.98B 72.34B 3,101B | 11.93B 10.4B 9.8B 8.92B 16.73B 1,143B 16.75B 117B 45.22B 582B 44.82B 43.82B 1,879B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 22/09/26 | GBX 12,560.00 | +0.48% | 1,773,894 |
| 18/09/26 | GBX 12,500.00 | +0.58% | 6,543,165 |
| 17/09/26 | GBX 12,428.00 | +2.41% | 2,815,366 |
| 16/09/26 | GBX 12,136.00 | +0.17% | 5,327,145 |
| 15/09/26 | GBX 12,116.00 | -0.31% | 3,056,945 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- AZN Stock
Select your edition
All financial news and data tailored to specific country editions
